370 related articles for article (PubMed ID: 20384749)
21. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.
Yue B; Yang Q; Xu J; Lu Z
Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275
[TBL] [Abstract][Full Text] [Related]
23. A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads.
Torok H; Taylor S; Baumann L; Jones T; Wieder J; Lowe N; Jarret M; Rich P; Pariser D; Tschen E; Martin D; Menter A; Weiss J
J Drugs Dermatol; 2005; 4(5):592-7. PubMed ID: 16167418
[TBL] [Abstract][Full Text] [Related]
24. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules.
Kim HR; Ha JM; Park MS; Lee Y; Seo YJ; Kim CD; Lee JH; Im M
J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
[TBL] [Abstract][Full Text] [Related]
26. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
[TBL] [Abstract][Full Text] [Related]
27. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
[TBL] [Abstract][Full Text] [Related]
28. A case of mottled hypopigmentation after low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser therapy.
Ryu HJ; Kim J
J Cosmet Laser Ther; 2013 Oct; 15(5):290-2. PubMed ID: 23464754
[TBL] [Abstract][Full Text] [Related]
29. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma.
Laothaworn V; Juntongjin P
J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121
[No Abstract] [Full Text] [Related]
30. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma.
Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST
J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754
[TBL] [Abstract][Full Text] [Related]
31. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma.
Ferreira Cestari T; Hassun K; Sittart A; de Lourdes Viegas M
J Cosmet Dermatol; 2007 Mar; 6(1):36-9. PubMed ID: 17348994
[TBL] [Abstract][Full Text] [Related]
32. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma.
Chan R; Park KC; Lee MH; Lee ES; Chang SE; Leow YH; Tay YK; Legarda-Montinola F; Tsai RY; Tsai TH; Shek S; Kerrouche N; Thomas G; Verallo-Rowell V
Br J Dermatol; 2008 Sep; 159(3):697-703. PubMed ID: 18616780
[TBL] [Abstract][Full Text] [Related]
33. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
Monheit GD; Dreher F
J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.
Park SJ; Park JW; Seo SJ; Park KY
Dermatol Ther; 2022 Mar; 35(3):e15287. PubMed ID: 34962047
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of dual-pulsed 1064 nm Q-switched Nd:YAG laser and single-pulsed 1064 nm Q-switched Nd:YAG laser by using zebrafish model and prospective split-face analysis of facial melasma.
Jang HW; Chun SH; Park HC; Ryu HJ; Kim IH
J Cosmet Laser Ther; 2017 Apr; 19(2):114-123. PubMed ID: 27911108
[TBL] [Abstract][Full Text] [Related]
36. A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream.
Bhawan J; Grimes P; Pandya AG; Keady M; Byers HR; Guevara IL; Colón LE; Johnson LA; Gottschalk R
Am J Dermatopathol; 2009 Dec; 31(8):794-8. PubMed ID: 19755910
[TBL] [Abstract][Full Text] [Related]
37. Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study.
Passeron T; Fontas E; Kang HY; Bahadoran P; Lacour JP; Ortonne JP
Arch Dermatol; 2011 Sep; 147(9):1106-8. PubMed ID: 21931054
[No Abstract] [Full Text] [Related]
38. Formation of new melasma lesions in the periorbital area following high-fluence, 1064-nm, Q-switched Nd/YAG laser.
Lee WJ; Kim YJ; Noh TK; Chang SE
J Cosmet Laser Ther; 2013 Jun; 15(3):163-5. PubMed ID: 23656545
[TBL] [Abstract][Full Text] [Related]
39. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans.
Lee Y; Choi EH; Lee SW
Dermatol Surg; 2012 Jan; 38(1):31-7. PubMed ID: 22093176
[TBL] [Abstract][Full Text] [Related]
40. Commentary on Clinical and Histopathological Assessment of Facial Melasma After Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser.
Morton LM
Dermatol Surg; 2016 Apr; 42(4):513-4. PubMed ID: 26949932
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
